The Indian pharmaceutical giant, Wockhardt, is facing financial distress and this presents an unmissable opportunity for major players in the global pharmaceutical market. A recent fall in stock value has signaled potential vulnerability, making it a prime acquisition for companies looking to increase their influence. With a rich history and exper… Read More